Clinical effect of point application combined with desomumab in the treatment of postmenopausal osteoporosis
- Conditions
- Postmenopausal osteoporosis
- Registration Number
- ITMCTR2200006016
- Lead Sponsor
- The Second Affiliated Hospital of Zhejiang Chinese Medicine University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
? Through bone mineral density examination, according to the lumbar bone mineral density (BMD) measured by DXA, lumbar T=-2.5SD.
? The patient has normal menopause and has been menopausal for more than 5 years;
? Female patients aged between 50 and 80 years old;
? Those who are willing to be subjects, can guarantee to complete the treatment course and sign informed consent.
? Does not meet the diagnostic criteria of osteoporosis;
? Diabetes mellitus, thyroid or parathyroid functional changes, osteomalacia, rheumatoid arthritis, multiple myeloma, bone tumors, Paget's disease, osteogenesis imperfection and other diseases that seriously affect bone metabolism;
? Uterus and ovaries removed;
(4) those who have used hormones, calcitonin or other drugs affecting bone metabolism within six months;
? Patients with serious cardiovascular and cerebrovascular diseases or liver and kidney failure;
? Other diseases and factors that can cause secondary osteoporosis.
Patients with a history of severe skin allergy or skin sensitivity
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone mineral density;
- Secondary Outcome Measures
Name Time Method TCM clinical symptom score;Bone metabolic index;